XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.2
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Distributions in Excess of Accumulated Net Income
Accumulated Comprehensive Income
Balance beginning of period (in shares) at Dec. 31, 2022   67,472,553      
Balance beginning of period at Dec. 31, 2022 $ 1,603,909 $ 67 $ 5,456,968 $ (3,879,847) $ 26,721
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,133     1,133  
Unrealized gain (loss) on derivatives (3,317)       (3,317)
Reclassification to interest expense, net (2,892)       (2,892)
Distributions declared (14,548)     (14,548)  
Stock-based compensation, net (in shares)   36,088      
Stock-based compensation, net 2,120 $ 1 2,119    
Balance end of period (in shares) at Mar. 31, 2023   67,508,641      
Balance end of period at Mar. 31, 2023 1,586,405 $ 68 5,459,087 (3,893,262) 20,512
Balance beginning of period (in shares) at Dec. 31, 2022   67,472,553      
Balance beginning of period at Dec. 31, 2022 1,603,909 $ 67 5,456,968 (3,879,847) 26,721
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 3,201        
Unrealized gain (loss) on derivatives 7,518        
Balance end of period (in shares) at Jun. 30, 2023   67,531,335      
Balance end of period at Jun. 30, 2023 1,582,937 $ 68 5,461,253 (3,905,747) 27,363
Balance beginning of period (in shares) at Mar. 31, 2023   67,508,641      
Balance beginning of period at Mar. 31, 2023 1,586,405 $ 68 5,459,087 (3,893,262) 20,512
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 2,068     2,068  
Unrealized gain (loss) on derivatives 10,835       10,835
Reclassification to interest expense, net (3,984)       (3,984)
Distributions declared (14,553)     (14,553)  
Stock-based compensation, net (in shares)   22,694      
Stock-based compensation, net 2,166   2,166    
Balance end of period (in shares) at Jun. 30, 2023   67,531,335      
Balance end of period at Jun. 30, 2023 $ 1,582,937 $ 68 5,461,253 (3,905,747) 27,363
Balance beginning of period (in shares) at Dec. 31, 2023 67,807,831 67,807,831      
Balance beginning of period at Dec. 31, 2023 $ 1,554,044 $ 68 5,468,728 (3,932,826) 18,074
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 2,900     2,900  
Unrealized gain (loss) on derivatives 7,319       7,319
Reclassification to interest expense, net (3,317)       (3,317)
Distributions declared (15,360)     (15,360)  
Stock-based compensation, net (in shares)   66,697      
Stock-based compensation, net 2,463   2,463    
Balance end of period (in shares) at Mar. 31, 2024   67,874,528      
Balance end of period at Mar. 31, 2024 $ 1,548,049 $ 68 5,471,191 (3,945,286) 22,076
Balance beginning of period (in shares) at Dec. 31, 2023 67,807,831 67,807,831      
Balance beginning of period at Dec. 31, 2023 $ 1,554,044 $ 68 5,468,728 (3,932,826) 18,074
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 4,398        
Unrealized gain (loss) on derivatives $ 9,705        
Balance end of period (in shares) at Jun. 30, 2024 67,917,128 67,917,128      
Balance end of period at Jun. 30, 2024 $ 1,535,573 $ 68 5,473,515 (3,959,158) 21,148
Balance beginning of period (in shares) at Mar. 31, 2024   67,874,528      
Balance beginning of period at Mar. 31, 2024 1,548,049 $ 68 5,471,191 (3,945,286) 22,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,498     1,498  
Unrealized gain (loss) on derivatives 2,386       2,386
Reclassification to interest expense, net (3,314)       (3,314)
Distributions declared (15,370)     (15,370)  
Stock-based compensation, net (in shares)   42,600      
Stock-based compensation, net $ 2,324   2,324    
Balance end of period (in shares) at Jun. 30, 2024 67,917,128 67,917,128      
Balance end of period at Jun. 30, 2024 $ 1,535,573 $ 68 $ 5,473,515 $ (3,959,158) $ 21,148